Elmsford, NY – According to filings with the U.S. Securities and Exchange Commission, NanoVibronix is raising $6,562,500.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Brian Murphy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NanoVibronix

NanoVibronix develops innovative ultrasound therapy devices based on its proprietary therapeutic ultrasound technology. Our products employ small, disposable transducers that transmit low frequency, low intensity ultrasound acoustic waves. These devices address a range of clinical applications helping eliminate pain, repair and regenerate tissue in musculoskeletal / vascular structures and decrease bio?lm formation on urinary catheters thus reducing risk of Catheter Associated Urinary Tract Infections (CAUTI). Due to their effectiveness, size and ease of use, these products help promote patient independence and enable cost-effective home-based care.

To learn more about NanoVibronix, visit

Contact:
Brian Murphy, Chief Executive Officer
914-233-3004
bmurphy@nanovibronix.com
https://www.linkedin.com/in/brianmurphynano/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved